Qlik Case Studies QlikView gave ALK-Abelló a crucial overview

Edit This Case Study Record

	QlikView gave ALK-Abelló a crucial overview Qlik

QlikView gave ALK-Abelló a crucial overview

Qlik

Technology Category	Analytics & Modeling - Real Time Analytics
Applicable Industries	Healthcare & Hospitals
Applicable Functions	Product Research & Development Quality Assurance
Use Cases	Predictive Quality Analytics
Services	Data Science Services
Challenge	ALK-Abelló, a global leader in the development and production of allergy diagnosis drugs and vaccines, was facing a crucial phase of getting their flagship product GRAZAX® approved by the European medical regulatory agencies. The European Mutual Recognition Procedure for new medical products is subject to very strict deadlines and is compulsory prior to any product release on the market. ALK-Abelló used the data management system Oracle Clinical, but with the strict and short deadlines to deliver answers ahead, a doubt rose whether in terms of resources it would work and whether it would be possible to create the needed overview in time. As 4-5 employees in the company had the competences to create overview and to retrieve data from the database, it could easily turn out being a catastrophic bottleneck. Read More
About Customer	ALK-Abelló is a global leader within the development and production of drugs used for the diagnosis of allergy and for vaccines against allergy. The company is expanding and works with the latest technology within research, development, and production. ALK-Abelló’s head office is located in Hørsholm, north of Copenhagen. The company had a turnover of DKK 1.7 billion in 2007 and has 1200 employees worldwide. The company was in the process of getting their flagship product GRAZAX® approved by the European medical regulatory agencies. Read More
Solution	ALK-Abelló implemented a test version of QlikView in just 14 days and the results were very convincing. They could rapidly create an overview of their very complex clinical database and realized right away that QlikView would be a good investment. It was easy to install and they could instantly analyze data across many different parameters. In a MRP procedure, which really can be described as an eye of a needle, they have to provide answers to many different questions, as for instance whether side effects can be related to age, gender, pregnancy etc. or to a vast combination of these parameters. With QlikView any of the unit’s employees can deliver this information, quickly. During 2008 ALK-Abelló will use QlikView on all their data. It will give them the opportunity to analyze data across many different parameters and to make all parts of the MRP procedure much more efficient than before. Read More Log in to view content
Contents

Technology Category

Analytics & Modeling - Real Time Analytics

Applicable Industries

Healthcare & Hospitals

Applicable Functions

Product Research & Development

Quality Assurance

Use Cases

Predictive Quality Analytics

Services

Data Science Services

Challenge

ALK-Abelló, a global leader in the development and production of allergy diagnosis drugs and vaccines, was facing a crucial phase of getting their flagship product GRAZAX® approved by the European medical regulatory agencies. The European Mutual Recognition Procedure for new medical products is subject to very strict deadlines and is compulsory prior to any product release on the market. ALK-Abelló used the data management system Oracle Clinical, but with the strict and short deadlines to deliver answers ahead, a doubt rose whether in terms of resources it would work and whether it would be possible to create the needed overview in time. As 4-5 employees in the company had the competences to create overview and to retrieve data from the database, it could easily turn out being a catastrophic bottleneck.

About Customer

ALK-Abelló is a global leader within the development and production of drugs used for the diagnosis of allergy and for vaccines against allergy. The company is expanding and works with the latest technology within research, development, and production. ALK-Abelló’s head office is located in Hørsholm, north of Copenhagen. The company had a turnover of DKK 1.7 billion in 2007 and has 1200 employees worldwide. The company was in the process of getting their flagship product GRAZAX® approved by the European medical regulatory agencies.

Solution

ALK-Abelló implemented a test version of QlikView in just 14 days and the results were very convincing. They could rapidly create an overview of their very complex clinical database and realized right away that QlikView would be a good investment. It was easy to install and they could instantly analyze data across many different parameters. In a MRP procedure, which really can be described as an eye of a needle, they have to provide answers to many different questions, as for instance whether side effects can be related to age, gender, pregnancy etc. or to a vast combination of these parameters. With QlikView any of the unit’s employees can deliver this information, quickly. During 2008 ALK-Abelló will use QlikView on all their data. It will give them the opportunity to analyze data across many different parameters and to make all parts of the MRP procedure much more efficient than before.

Impact #1	Opportunity to make collection of data and information more efficient in a market characterized by tough competition
Impact #2	Eliminates the competence bottleneck
Impact #3	Provides a quick and efficient overview of complex clinical database prior to MRP procedure

Impact #1

Opportunity to make collection of data and information more efficient in a market characterized by tough competition

Impact #2

Eliminates the competence bottleneck

Impact #3

Provides a quick and efficient overview of complex clinical database prior to MRP procedure

Benefit #1	ROI in 1-2 month

Benefit #1

ROI in 1-2 month

Download PDF Version

Overview

QlikView gave ALK-Abelló a crucial overview

Operational Impact

Quantitative Benefit